Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry.

Autor: Cancilla MT; Sunesis Pharmaceuticals, Inc., 395 Oyster Point Boulevard, Suite 400, South San Francisco, CA 94080, USA., He MM, Viswanathan N, Simmons RL, Taylor M, Fung AD, Cao K, Erlanson DA
Jazyk: angličtina
Zdroj: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2008 Jul 15; Vol. 18 (14), pp. 3978-81. Date of Electronic Publication: 2008 Jun 10.
DOI: 10.1016/j.bmcl.2008.06.011
Abstrakt: We demonstrate a fragment-based lead discovery method that combines site-directed ligand discovery with dynamic combinatorial chemistry. Our technique targets dynamic combinatorial screening to a specified region of a protein by using reversible disulfide chemistry. We have used this technology to rapidly identify inhibitors of the drug target Aurora A that span the purine-binding site and the adaptive pocket of the kinase. The binding mode of a noncovalent inhibitor has been further characterized through crystallography.
Databáze: MEDLINE